ORIC Pharmaceuticals, Inc. (ORIC) - Quarterly Income Statement

Home
ORIC
Financials

4.69 (USD) • At close April 16, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	0	0	1.538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.272	0.261	0.263	0.257	0.259	0.253	0.247	0.221	0.247	0.251	0.229	0.217	0.222	0.229	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	-0.272	-0.261	1.275	-0.257	-0.259	-0.253	-0.247	-0.221	-0.247	-0.251	-0.229	-0.217	-0.222	-0.229	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.829	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	31.97	31.202	28.94	21.96	24.481	22.388	18.787	19.516	16.295	14.723	13.834	16.828	16.745	12.899	15.517	11.697	12.113	8.831	7.723	7.254	6.96	5.632	5.04	5.212
General & Administrative Expenses Numbers are in millions	7.6	7.116	7.077	7.03	6.947	6.294	6.205	6.162	5.824	5.971	6.862	6.43	6.06	5.557	5.54	4.856	4.297	3.8	3.4	1.925	1.811	1.465	1.315	1.134
Selling & Marketing Expenses Numbers are in millions	0	0	0	-0.261	-0.263	0	0	0	0	0	0	0	0	0	0	0	24.843	0	0	0	0	0	0	0
SG&A Numbers are in millions	7.6	7.116	7.077	6.769	6.684	6.294	6.205	6.162	5.824	5.971	6.862	6.43	6.06	5.557	5.54	4.856	4.297	3.8	3.4	1.925	1.811	1.465	1.315	1.134
Other Expenses Numbers are in millions	0	0	0	3.979	3.098	3.204	2.048	1.733	5	5	0.409	0	-11.697	0	0.015	0	-0.007	0.044	0.074	0.066	0.074	0.072	0.073	0.07
Operating Expenses Numbers are in millions	39.57	38.318	36.017	28.729	31.165	28.682	24.992	25.678	22.119	20.694	20.696	23.258	22.805	18.456	21.057	16.553	16.41	12.631	11.123	9.179	8.771	7.097	6.355	6.346
Operating Income Numbers are in millions	-39.57	-38.318	-36.017	-28.99	-31.428	-28.682	-24.992	-25.678	-22.119	-25.694	-20.696	-23.258	-22.805	-18.456	-21.057	-16.553	-28.282	-25.602	-11.123	-9.179	-8.771	-7.097	-6.355	-6.346
Operating Income Ratio Numbers are in millions	0	0	0	0	-20.434	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.263	3.752	4.054	3.979	3.098	3.204	2.048	1.733	1.272	0.865	0.409	0.099	0.034	0.03	0.048	0.044	0.023	0.054	0.099	0.307	0.417	0.548	0.39	0.331
Income Before Tax Numbers are in millions	-36.307	-34.566	-31.963	-25.011	-28.33	-25.478	-22.944	-23.945	-20.847	-24.829	-20.287	-23.159	-22.771	-18.426	-21.009	-16.509	-28.259	-25.548	-11.024	-8.872	-8.354	-6.549	-5.965	-6.015
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-18.42	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0.218	2.243	-0.257	0.137	-1.986	-1.272	-0.865	0	-0.099	-0.034	-0.03	-0.033	-0.088	-0.03	-0.01	-0.025	-0.548	-0.417	-0.548	-0.39	-0.592
Net Income Numbers are in millions	-36.307	-34.566	-31.963	-25.011	-28.33	-25.478	-22.944	-21.959	-19.575	-23.964	-20.287	-23.06	-22.771	-18.426	-21.009	-16.509	-28.259	-25.548	-11.024	-8.872	-8.354	-6.549	-5.965	-6.015
Net Income Ratio Numbers are in millions	0	0	0	0	-18.42	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.51	-0.49	-0.45	-0.37	-0.49	-0.44	-0.5	-0.49	-0.49	-0.61	-0.51	-0.58	-0.58	-0.47	-0.57	-0.45	-0.84	-0.84	-0.51	-0.32	-0.44	-0.34	-0.31	-0.31
EPS Diluted Numbers are in millions	-0.51	-0.49	-0.45	-0.37	-0.49	-0.44	-0.5	-0.49	-0.49	-0.61	-0.51	-0.58	-0.58	-0.47	-0.57	-0.45	-0.84	-0.84	-0.51	-0.32	-0.44	-0.34	-0.31	-0.31
EBITDA Numbers are in millions	-39.266	-38.048	-35.745	-28.729	-31.165	-28.425	-24.733	-25.425	-21.872	-20.473	-20.449	-23.007	-22.576	-18.239	-20.835	-16.324	-16.176	-12.391	-10.877	-8.929	-8.501	-6.827	-6.109	-6.104
EBITDA Ratio Numbers are in millions	0	0	0	0	-20.263	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC Add to watchlist

NASDAQ:ORIC